Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07216781
PHASE1

Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

Sponsor: Minicircle

View on ClinicalTrials.gov

Summary

The purpose of this study is to investigate the safety and efficacy of a gene therapy for Klotho, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of the Klotho gene therapy.

Official title: Evaluating the Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans: An Interventional, Non-Placebo-Controlled Pilot Phase Study

Key Details

Gender

All

Age Range

23 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2025-10-06

Completion Date

2026-08

Last Updated

2026-02-17

Healthy Volunteers

Yes

Conditions

Interventions

GENETIC

Injectable Plasmid Klotho Gene Therapy

Injection of plasmid-delivered Klotho gene therapy

Locations (2)

Apeiron Center

Austin, Texas, United States

GARM Clinic

Roatán, Bay Islands, Honduras